• Recommend
  • Tweet
  • Print
  • Email

The Health Section develops policy positions that promote biomedical innovation and represent the best interests of BIO member companies with a direct interest in human health. Among the priority issues the Health Section focuses on are matters affecting the healthcare-related regulatory and reimbursement climate, pandemic and biodefense preparedness, publicly-funded scientific research, and personalized medicine. The Health Section is managed by a Section governing body and recommends members to sit on BIO's Board of Directors.
Staff Contact: Sara Radcliffe

Hide Date: 
Hide Date